You are here

  • Home
  • Archive
  • Volume 20, Issue Suppl 1
  • GRP-041 Collection and Analysis of Adverse Effects and Co-Medications For Outpatients Receiving Boceprevir- or Telaprevir-Based Treatment For Chronic Hepatitis C

Citation Tools

Article menu

Download PDFPDF

General and risk management, patient safety
GRP-041 Collection and Analysis of Adverse Effects and Co-Medications For Outpatients Receiving Boceprevir- or Telaprevir-Based Treatment For Chronic Hepatitis C
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Carré N, Lemaître G, Abbas N, et al
GRP-041 Collection and Analysis of Adverse Effects and Co-Medications For Outpatients Receiving Boceprevir- or Telaprevir-Based Treatment For Chronic Hepatitis C
European Journal of Hospital Pharmacy 2013;20:A15.